Articles
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
Let’s Talk FCA: Top False Claims Act Developments of 2020 and a Look Ahead (March 2021)
Defendants’ Own Lawsuits Showed Knowledge of Regulation Effective Date; United States District Court for the District of Colorado No. 18-cv-00792-RBJ, U.S. ex rel. Kathryn McIver, et al. v. ACT for Health Inc., et al.
Automatic Billing System Strongly Suggests Submission of False Claims; United States District Court for the Western District of Texas, Austin Division, No. 1:18-cv-00806-RP, U.S. ex rel. Cecelia Young v. Kindred Healthcare, et al.
S.A. Taylor to Pay Over Half Million Dollars to Settle Allegations of Prevailing Wage Fraud
DOJ Announces FCA Settlement Arising out of Violation of SBA’s Joint Venture Requirements
Responses Matter: Securities Fraud Sentence Shows the Value of a Sound Response to a Government Investigation
Fraudulent Pricing Not Actionable Without Evidence Government Paid It; United States District Court for the District of Maryland No. No. SAG-17-0570, U.S. ex rel. David Harris v. Ellison Systems Inc.
Non-Parties Duck Subpoenas Seeking Minimally Relevant Information; United States District Court for the Western District of North Carolina No. 3:16-CV-00750-GCM, U.S. ex rel. Daniel Hayes M.D. v. Charlotte Mecklenburg Hospital Authority
I’m a Relator, Not a Doctor! Lack of Billing, Medical Knowledge Dooms Medicare Fraud Claims; United States District Court for the Middle District of Florida No. 8:16-cv-961-T-27AEP, U.S. ex rel. Delia Bell v. Cross Garden Care Center LLC, et al.
SFO Investigation Powers Over Foreign Companies Limited by U.K. Supreme Court Decision
Bioventus Settles for $3.6 Million over Improper Medical Necessity Claims
District Court Issues Rare Rebuke Denying DOJ’s Belated Motion to Intervene
The False Claims Act and Health Care: 2020 Recoveries and 2021 Outlook
FCA Retaliation Claim Not Covered by Relator’s Arbitration Agreement; United States District Court for the Middle District of Tennessee, Nashville Division, No. 3:13-CV-01025, U.S. ex rel. Paul Dorsa v. Miraca Life Sciences Inc.
Sixth Circuit Finds No Appealable Issue in Denial of Motion to Dismiss; United States Court of Appeals for the Sixth Circuit No. 20-5007, U.S. ex rel. Paul Dorsa v. Miraca Life Sciences Inc.
CMS Statement Clarifies Agency’s View that the Stark Law Final Rule is Effective
District Court Judge Calls for Investigation of Prosecutorial Misconduct in Disclosure Failures
Koehler on the Broad Scope and Inconsistent Enforcement of the FCPA
Qui Tam Quarterly – Risky Business: Health Care Investments Pose Acute False Claims Act Risk for Private Equity
Keep reading
